Skip to content
U.S. Transhumanist Party – Official Website
  • Home
  • Posts
  • Values
  • Platform
  • Leadership
  • Advisors
  • Candidates
  • Highlights
  • FAQ
  • States & Allies
  • Free Membership
  • Facebook
  • Twitter
  • Search Icon

U.S. Transhumanist Party – Official Website

U.S. Transhumanist Party – PUTTING SCIENCE, HEALTH, & TECHNOLOGY AT THE FOREFRONT OF AMERICAN POLITICS

Breaking the Bottleneck: A Synergy of Technology and Medicine – Article by Zach Richardson

Breaking the Bottleneck: A Synergy of Technology and Medicine – Article by Zach Richardson

August 20, 2020 Zach Richardson Comments 0 Comment

logo_bg

Zach Richardson


In March of 2019, I began to have a very strange problem. I was breathing normally, but felt like I was suffocating. The problem became much worse when lying down, but seemed to come and go arbitrarily. Some days it would be really bad, and on others I didn’t even notice it. This happened twice in a week, and I checked with a doctor. He assured me I had anxiety and gave me a prescription for some anxiolytic medicine. I couldn’t breathe, and his solution was Xanax. I stupidly trusted him.

In May 2019, I ended up in the hospital. My body was turning yellow, and my liver, kidneys, and heart were failing. The cause was idiopathic; none of the 7 specialists knew why I was having congestive heart failure. A couple of drugs were tried, but in the end the only solution they said would save my life was the implantation of a mechanical device that would help my heart pump: a Ventricular Assist Device, or VAD.

I was lucky enough to be selected as a perfect candidate for a clinical trial, partially due to being particularly young for having Congestive Heart Failure (CHF). A new version of an already cutting-edge technology would be tested on my body, and the results would be recorded for their study. The machine they implanted was called the Heartmate 3, and it saved my life.

The VAD is currently used either as “bridge” or “destination” therapy, with “bridge” meaning that it is used only temporarily until one can get a heart transplant, and “destination” meaning that one is ineligible for transplant at all, and will have the VAD for the rest of one’s life. Some of the contraindications for VAD implantation being bridge therapy include being obese or over 65 years of age. Luckily, I am not either of those two, and therefore am eligible for a transplant. However, there are two factors that are going to lead to it likely being an extremely long time before a donor heart is available. One is that I am a larger man, standing at 6 feet tall, meaning I require a larger-than-average heart. The other is that I have Type O blood, which is the hardest from the standpoint of receiving an organ donation.

This puts me in a very interesting situation, where I am a young man who may have many years still ahead of him with an implanted device. It may be 7 years from now when I get the call for transplant, or it may be tomorrow. If it happens 7 years from now, there may be therapies that will have been developed that would allow me to regrow my heart, or clone one from my stem cells, and thereby avoid having to be on a cocktail of immunosuppressants indefinitely. Unfortunately, even Athersys only has CHF treatments in the preclinical stage, which means I may have to wait a while. I intensely wish those trials weren’t being constrained like they are.

Having set significant life extension towards the very top of my hierarchy of values, I am extremely grateful that I live in a society where these technologies are available to me. I have a highly personal interest in seeing a society of scientists and biomedical engineers emerge to help develop these technologies! However, part of my situation was just me getting lucky: I had the treatment I needed approved just months before receiving it, and happened to have top-notch insurance.

One unfortunate side effect of having a centralized regulatory system is that the Food and Drug Administration (FDA) is only held responsible for what are known as “Type I Errors”. A Type I error is where the FDA passes an unsafe drug or treatment, leading to harm to an individual or group. Unfortunately, this means that FDA officials do not seem to care at all about “Type II Errors”, where they do not pass a life-saving treatment or drug in time to save someone’s life. The FDA is so terrified of having another Vioxx incident, that FDA officials are overly cautious in approving the use of radically innovative and breakthrough technologies. The fact that these technologies carry some risk is something of no worry to someone who is going to die if they don’t get the treatment. It is much harder to blame the FDA for being too safe than it is to blame them for being reckless.

This is why I am proud to be a member of the U.S. Transhumanist Party (USTP), where science and technology are put at the forefront of American politics. The current bottleneck those like me with CHF face is regulatory hurdles. Article VI, Section VI, of the USTP Constitution states: “The United States Transhumanist Party upholds morphological freedom—the right to do with one’s physical attributes or intelligence whatever one wants so long as it does not directly harm others.” Right now what I and others with CHF would like to do is to get a stem-cell heart. We are being hindered not by direct legislation restricting morphological freedom, but by the far more pernicious hindrance of excessive regulatory burden. The treatments we want are being developed exponentially slower than they could be, because each step of the way has to adhere to draconian testing standards. This means a lot of Type II errors are being committed. We are not being told, “You cannot get this treatment.” Providers are being told, “You cannot provide this treatment.”

In my ideal world, regulatory agencies would work more like Underwriters Laboratories or Quality Assurance International. Leaving regulatory activity to the market, far from the fearmongering of producing dangerous and shoddy drugs and treatments, would instead invigorate the institutions as they would compete to certify the best products and treatments for consumers, since their names and reputations would be on the line.

I believe there needs to be a much stronger focus in regulatory institutions toward the elimination of Type II Errors, because there are a lot of sick people going untreated.

Zach Richardson is the Director of Publication for the U.S. Transhumanist Party. He is a Certified Supply Chain Professional and small-business co-owner who produced respirator-style masks to help stem the tide of COVID-19’s spread. 


Guest Articles
approval, clinical trials, Drugs, FDA, Food and Drug Administration, health, health care, healthcare, medicine, morphological freedom, patients' rights, Type I error, Type II error, united states, Zach Richardson

Post navigation

PREVIOUS
U.S. Transhumanist Party Chairman Gennady Stolyarov II’s Update Interview on the Archer Report – July 24, 2020
NEXT
Petition by Biogerontology Global to Declare Aging the Top Global Risk

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Social Media

Constitution of the U.S. Transhumanist Party

Transhumanist Bill of Rights – Version 3.0

U.S. Transhumanist Party Facebook Feed

Free Transhumanist Symbols

Guidelines for Community Conduct

SUBMIT A POST

Subject Categories

    - Life Extension
    - Artificial Intelligence
    - Space Colonization
    - Robotics
    - Biotechnology
    - Nanotechnology
    - Autonomous Vehicles
    - 3D Printing
    - Cryptocurrencies
    - Vertical Farming
    - Universal Basic Income
    - Existential Risk
    - Rationality

Hashtags

    #USTranshumanistParty, #TranshumanistParty, #TranshumanistPolitics, #TomRoss2024, #RossTwedt2024

Recent Posts

  • Why Is Trump So Intent on Sending Illegal Immigrant Noncriminals to Prison Camps in El Salvador? – Article by Alex Nowrasteh
  • Tribute to John Kerecz (1961 – 2025)
  • The Copenhagen Consensus – How to Feed the Hungry – Article by Zach Richardson
  • The Issue of Food – Article by Luis Arroyo
  • Results of Platform Vote #9 and Vote on Proposals on Investigations and Emergency Declarations; Adopted Sections of the U.S. Transhumanist Party Constitution
  • Official Ballot Options for Platform Vote #9 and Proposals on Investigations and Emergency Declarations
  • Gennady Stolyarov I and Gennady Stolyarov II Discuss the Progress of Information Technology (2019)
  • Immortality: My Quest and Reasons for Seeking an Indefinite Lifespan – Article by Albi Ndoni
  • U.S. Transhumanist Party General Discussion Thread for 2025
  • U.S. Transhumanist Party Statement on the Murder of Brian Thompson
  • News Regarding THPedia, the Transhumanist Encyclopedia for Everyone – Invitation to Contribute – Statement by Gennady Stolyarov II
  • The Transhumanist Council: A Worthy Effort for a New Umbrella Transhumanist Organization
  • Report on the Montana Right to Try Act – Analysis by Shamar White
  • U.S. Transhumanist Party Comments on the Citizen Petition by Age Reversal Unity to Declare Aging a Disease
  • U.S. Transhumanist Party Chairman’s Eighth Anniversary Message
  • U.S. Transhumanist Party Statement on the Outcome of the 2024 U.S. Presidential Election
  • Preliminary Member-Reported Write-In Totals for Tom Ross and Daniel Twedt in the 2024 U.S. Presidential Election
  • U.S. Transhumanist Party and Nevada Transhumanist Party Positions on 2024 Nevada Ballot Questions
  • Where to Write In Tom Ross for President of the United States – and How to Make Sure Your Vote Counts
  • Celebration of U.S. Transhumanist Party 10th Anniversary and International Longevity Month

Recent Comments

  • R. Nicholas Starr on U.S. Transhumanist Party General Discussion Thread for 2025
  • Luis Arroyo on Tribute to John Kerecz (1961 – 2025)
  • shamar on U.S. Transhumanist Party General Discussion Thread for 2025
  • Gennady Stolyarov II on U.S. Transhumanist Party General Discussion Thread for 2025
  • Theo Ibrahim on The Issue of Food – Article by Luis Arroyo

Archives

  • June 2025 (1)
  • May 2025 (1)
  • March 2025 (3)
  • February 2025 (1)
  • January 2025 (3)
  • December 2024 (2)
  • November 2024 (6)
  • October 2024 (3)
  • September 2024 (2)
  • August 2024 (5)
  • July 2024 (4)
  • June 2024 (3)
  • May 2024 (1)
  • March 2024 (1)
  • February 2024 (1)
  • January 2024 (8)
  • October 2023 (11)
  • September 2023 (6)
  • August 2023 (1)
  • July 2023 (4)
  • May 2023 (3)
  • April 2023 (3)
  • March 2023 (2)
  • February 2023 (12)
  • January 2023 (23)
  • December 2022 (2)
  • November 2022 (2)
  • October 2022 (3)
  • August 2022 (3)
  • July 2022 (2)
  • May 2022 (6)
  • March 2022 (3)
  • February 2022 (4)
  • January 2022 (7)
  • December 2021 (11)
  • November 2021 (4)
  • October 2021 (5)
  • September 2021 (2)
  • August 2021 (2)
  • July 2021 (3)
  • June 2021 (2)
  • May 2021 (6)
  • April 2021 (7)
  • March 2021 (4)
  • February 2021 (5)
  • January 2021 (6)
  • December 2020 (10)
  • November 2020 (4)
  • October 2020 (2)
  • September 2020 (1)
  • August 2020 (4)
  • July 2020 (5)
  • June 2020 (6)
  • May 2020 (3)
  • April 2020 (3)
  • March 2020 (6)
  • February 2020 (1)
  • January 2020 (6)
  • December 2019 (3)
  • November 2019 (2)
  • October 2019 (9)
  • September 2019 (10)
  • August 2019 (12)
  • July 2019 (18)
  • June 2019 (17)
  • May 2019 (12)
  • April 2019 (8)
  • March 2019 (12)
  • February 2019 (7)
  • January 2019 (13)
  • December 2018 (9)
  • November 2018 (5)
  • October 2018 (9)
  • September 2018 (5)
  • August 2018 (10)
  • July 2018 (13)
  • June 2018 (14)
  • May 2018 (8)
  • April 2018 (8)
  • March 2018 (10)
  • February 2018 (15)
  • January 2018 (17)
  • December 2017 (8)
  • November 2017 (17)
  • October 2017 (19)
  • September 2017 (11)
  • August 2017 (11)
  • July 2017 (16)
  • June 2017 (15)
  • May 2017 (10)
  • April 2017 (7)
  • March 2017 (8)
  • February 2017 (16)
  • January 2017 (8)
  • December 2016 (6)
  • November 2016 (5)

Categories

  • Allied Projects
  • Announcements
  • Art
  • Candidates
  • Debate
  • Discussion Panels
  • Distributed Computing
  • Exposure Periods
  • Foreign Ambassadors
  • General Discussion
  • Guest Articles
  • Inclusion
  • Interviews
  • Legislative Analysis
  • Official Ballots
  • Petitions
  • Platform
  • Presentations
  • Press Releases
  • Research
  • Sample Ballots
  • Science Fiction
  • Statements
  • Tolerance
  • Virtual Enlightenment Salons
  • Vote Results
  • Working Groups

Victor Run Virtual Race – June 4-6, 2021

Historical Archive – 2020 U.S. Presidential Ticket – Charlie Kam and Liz Parrish

© 2025   Copyright - U.S. Transhumanist Party - All Rights Reserved | WordPress design: Art Ramon Paintings